Invicta Diagnostic Ltd vs Pramodini Medicare Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Oct 25, 2026

Key Highlights

The Latest Trading Price of Invicta Diagnostic Ltd is ₹ 60.5 as of 23 Oct 15:30 . The P/E Ratio of Invicta Diagnostic Ltd changed from 16.1 on March 2026 to 0 on March 2023 . This represents a CAGR of -100.00% over 3 yearsThe P/E Ratio of Pramodini Medicare Ltd changed from 0 on March 2024 to 0 on March 2023 . This represents a CAGR of 0.0% over 5 years The Market Cap of Invicta Diagnostic Ltd changed from ₹ 79.2 crore on March 2026 to ₹ 0 crore on March 2023 . This represents a CAGR of -100.00% over 3 yearsThe Market Cap of Pramodini Medicare Ltd changed from ₹ 0 crore on March 2024 to ₹ 0 crore on March 2023 . This represents a CAGR of 0.0% over 5 years The Dividend Payout of Invicta Diagnostic Ltd changed from 0 % on March 2024 to 0 % on March 2023 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of Pramodini Medicare Ltd changed from 0 % on March 2024 to 0 % on March 2023 . This represents a CAGR of 0.0% over 5 years .

About Invicta Diagnostic Ltd

Invicta Diagnostic Limited was incorporated as Limited Liability Partnership under the name 'Invicta Diagnostic LLP' vide Certificate of Incorporation dated January 22, 2021 issued by Assistant Registrar of Companies, Central Registration Centre.
Further, Invicta Diagnostic LLP converted into a Private Limited Company as 'Invicta Diagnostic Private Limited' dated December 01, 2023.
Subsequently, Company converted from a Private Limited to a Public Limited Company, and the name was changed to 'Invicta Diagnostic Limited' and a fresh Certificate of Incorporation dated July 02, 2024 was issued by the Central Processing Centre. Invicta Diagnostic Limited is an innovative diagnostic chain in Mumbai Metropolitan Region (MMR) offering comprehensive radiology and pathology solutions.
It offer a one-stop solution for pathology and radiology testing services such as imaging (including radiology) and pathology/clinical laboratory to customers through a network, consisting of 8 diagnostic centres and 1 centralised laboratory across Mumbai Metropolitan Region in Maharashtra.

About Pramodini Medicare Ltd

Pramodini Medicare Limited was originally incorporated on September 12, 2000 as 'Pramodini Medicare Private Limited' with the Registrar of Companies, Andhra Pradesh.
Thereafter, the status of the Company changed to public limited Company and the name was changed to 'Pramodini Medicare Limited' vide fresh certificate of incorporation dated November 12, 2025. Company was originally incorporated in the year 2000 with the objective to provide diagnostic services.
The Company provide a range of technology-enabled diagnostic services such as radiology, clinical laboratory and nuclear medicine service to public hospitals, private hospitals, certain PSU (Public Sector Undertaking) of Government of India and medical colleges across tier I, tier II and tier III cities throughout India. Diagnostic services include a comprehensive range of offerings: (i) 'Radiology' which covers Magnetic Resonance Imaging (MRI), Computed Tomography (CT scan), X- ray, Ultrasound with colour doppler, Mammography, DEXA Scan and Intervention Radiology, (ii) 'Clinical Laboratory' which includes Haematology, Micro-Biology, Immunology, Pathology & Bio-Chemistry and (iii) 'Nuclear Medicine' which includes PET-CT (Positron Emission Tomography-Computed Tomography), SPECT (Single Photon Emission Computed Tomography) and Nuclear therapy.

FAQs for the comparison of Invicta Diagnostic Ltd and null

Which company has a larger market capitalization, Invicta Diagnostic Ltd or Pramodini Medicare Ltd?

Market cap of Invicta Diagnostic Ltd is 76 Cr while Market cap of Pramodini Medicare Ltd is 239 Cr

What are the key factors driving the stock performance of Invicta Diagnostic Ltd and Pramodini Medicare Ltd?

The stock performance of Invicta Diagnostic Ltd and Pramodini Medicare Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Invicta Diagnostic Ltd and Pramodini Medicare Ltd?

As of October 25, 2026, the Invicta Diagnostic Ltd stock price is INR ₹60.5. On the other hand, Pramodini Medicare Ltd stock price is INR ₹108.65.

How do dividend payouts of Invicta Diagnostic Ltd and Pramodini Medicare Ltd compare?

To compare the dividend payouts of Invicta Diagnostic Ltd and Pramodini Medicare Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.